|
 | Up a level |
Moskovich, D and Finkelshtein, Y and Alfandari, A and Rosemarin, A and Lifschytz, T and Weisz, A and Mondal, S and Ungati, H and Katzav, A and Kidron, D and Mugesh, G and Ellis, M and Lerer, B and Ashur-Fabian, O (2021) Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. In: Oncogene, 40 (44). 6248- 6257.
